Improved Drug Impurity ID Efficiency under CMC using 2-D LC/MS

Significance of the topic

Impurity profiling ensures drug safety and regulatory compliance in the Chemistry, Manufacturing and Control (CMC) phase of pharmaceutical production. A robust analytical platform that leverages existing non-volatile mobile phase conditions simplifies workflows and preserves validated HPLC methods.

Objectives and study overview

This report describes the design and evaluation of a trap-free two-dimensional liquid chromatography coupled to mass spectrometry (2D-LC/MS) system developed by Shimadzu and Eisai. The primary goal was to enable impurity identification under standard non-volatile HPLC conditions, minimizing method redevelopment and maintaining high sensitivity for trace-level impurities.

Methodology

The system employs a first-dimension HPLC separation using phosphate-based buffers, followed by peak fractionation into microvolume loops. A second-dimension column equipped with UV detection and a diverter valve performs desalting before electrospray ionization mass spectrometry (ESI-MS). Automated valve sequencing and time-program macros streamline the collection and analysis of multiple impurity fractions in a single batch run.

Used instrumentation

• Co-Sense 2D-LC/MS impurity identification system (Shimadzu-Eisai collaboration)
• First-dimension column: Shim-pack VP-ODS, 150 mm × 4.6 mm i.d., 5 µm
• Second-dimension column: Shim-pack XR-ODS, 75 mm × 2.0 mm i.d., 2.2 µm
• UV detector (270 nm monitoring)
• API-ESI mass spectrometer (m/z 100–1000, positive mode, 4.5 kV)
• LCMSsolution control software with macro-based time-program and batch scheduling

Main results and discussion

The trap-free 2D-LC/MS system successfully fractionated and identified impurities at the 0.1% level of a sulfadimethoxine standard containing four structurally related sulfa drug impurities. Retention time stability in the first dimension allowed precise loop collection. UV and MS chromatograms demonstrated clear separation and detection of each impurity. Mass spectra confirmed monoisotopic masses with sub-2 ppm accuracy.

Benefits and practical applications

• Maintains validated non-volatile HPLC conditions, avoiding revalidation and method transfer.
• Streamlines impurity identification in CMC workflows, reducing analysis time and resource demands.
• Macro-driven operation enables automated fractionation, batch scheduling, and data processing.
• Synchronized UV/MS data browsing facilitates rapid confirmation of impurity peaks against blanks.

Future trends and potential applications

Integration of real-time data processing algorithms and artificial intelligence could further accelerate impurity profiling. Expansion to three-dimensional separations and coupling with high-resolution MS will enhance trace-level detection. Broader adoption in quality control and metabolite studies is anticipated.

Conclusion

The trap-free 2D-LC/MS system offers an efficient and robust solution for impurity identification under CMC conditions. By leveraging existing HPLC methods and automated workflows, laboratories can achieve high-sensitivity impurity profiling without extensive method redevelopment.